Teligent (Teligent) Float Percentage Of Total Shares Outstanding : 99.99% (As of May. 19, 2024)

View and export this data going back to 1997. Start your Free Trial

What is Teligent Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Teligent's float shares is 92.81 Mil. Teligent's total shares outstanding is 92.82 Mil. Teligent's float percentage of total shares outstanding is 99.99%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Teligent's Insider Ownership is 5.68%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Teligent's Institutional Ownership is 0.02%.

Teligent Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Teligent's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	92.81	/	92.82
	=	99.99%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teligent (Teligent) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teligent Inc (OTCPK:TLGTQ) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

105 Lincoln Avenue, Buena, NJ, USA, 08310

Website

https://www.teligent.com

Teligent Inc is a specialty generic pharmaceutical company. Teligent develops, manufactures, and sells (under its own label) topical, injectable, complex, and ophthalmic pharmaceutical products in the U.S. and Canada. The product portfolio consists of hospital-based sterile injectable products and topical products (creams like Synalar and Spectazole; lotions like Kenalog; ointments like Topicort and Kenalog; and topical solutions like Pennsaid and Xylocaine). The company also offers services to the pharmaceutical, over-the-counter, and cosmetic markets.

Executives

Joseph Benesch	officer: VP, Controller, PAO	C/O TELIGENT, 105 LINCOLN AVENUE, BUENA NJ 08310
Alyssa Lozynski	officer: Interim CFO	C/O TELIGENT, INC. 105 LINCOLN AVENUE BUENA NJ 08310
William S Marth	director	236 GROVE STREET, WELLESLEY MA 02482
Philip K Yachmetz	officer: EVP, Chief Legal Off, Corp Sec	501 LAFAYETTE AVE WYCKOFF NJ 07481
R Carter Pate	director	5739 WORTHAM LANE, DALLAS TX 75252
De Paolantonio Ernest Robert	officer: Chief Financial Officer	4131 PARKLAKE AVENUE SUITE 225, RALEIGH NC 27612
Carole Ben-maimon	director	C/O IMPAX LABORATORIES, INC., 30831 HUNTWOOD AVENUE, HAYWARD CA 94544
Bhaskar Chaudhuri	director	ONE ENTERPRISE, ALISO VIEJO CA 92656
Sabatino Thomas J Jr	director	C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015
John E Celentano	director	C/O IGI LABORATORIES, INC., 105 LINCOLN AVENUE, BUENA NJ 08310
Steven H Koehler	director	C/O THE MEDICINES CO, 5 SYLVAN WAY, PARSIPPANY NJ 07054
Keith James	officer: Prin Acct Officer Controller	105 LINCOLN AVENUE BUENA NJ 08310
Life Sciences Opportunities Fund Ii Lp	10 percent owner	152 W 57TH STREET 19TH FLOOR NEW YORK NY 10019
Donald V Weir	10 percent owner	SANDERS MORRIS HARRIS, 600 TRAVIS, HOUSTON TX 77002
Timothy B. Sawyer	officer: CEO	C/O TELIGENT, INC. 105 LINCOLN AVENUE BUENA NJ 08310